Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology

J Adv Pract Oncol. 2023 Apr;14(3):223-226. doi: 10.6004/jadpro.2023.14.3.8. Epub 2023 Apr 1.

Abstract

In the popular biomarker-focused session at JADPRO Live 2022, presenters paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and reviewed recommendations and guidelines for biomarker testing.